Filing Details
- Accession Number:
- 0001110803-13-000302
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-05 18:39:29
- Reporting Period:
- 2013-09-03
- Filing Date:
- 2013-09-05
- Accepted Time:
- 2013-09-05 18:39:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1534166 | Nicholas Naclerio | 5200 Illumina Way San Diego CA 92122 | Sr Vp, Corporate & Venture Dev | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-09-03 | 59,000 | $43.37 | 83,559 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-09-03 | 37,515 | $76.37 | 46,044 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-09-03 | 13,066 | $77.47 | 32,978 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-09-03 | 8,022 | $78.37 | 24,956 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-09-03 | 397 | $78.96 | 24,559 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-09-03 | 59,000 | $0.00 | 59,000 | $43.37 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
96,000 | 2011-08-08 | 2020-06-29 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 37,515 shares sold ranging from $75.84 to $76.81 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 13,066 shares sold ranging from $76.89 to $77.88 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 8,022 shares sold ranging from $77.91 to $78.90 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 397 shares sold ranging from $78.91 to $78.99 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.